Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomewide screens in ankylosing spondylitis.

Matthew A Brown1

  • 1Diamantina Institute of Cancer, Immunology and Metabolic Medicine, Princess Alexandra Hospital, Woolloongabba, Qld, Australia. matt.brown@uq.edu.au

Advances in Experimental Medicine and Biology
|September 8, 2009
PubMed
Summary

Ankylosing spondylitis (AS) research seeks genes beyond HLA-B27, as studies show it’s not the sole genetic factor. This research explores AS genetic epidemiology and gene mapping to understand disease susceptibility and traits.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K
Genetic Screens02:46

Genetic Screens

5.3K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis.

Rheumatology (Oxford, England)·2026
Same author

Blood-based RNA-Seq of 5412 individuals with rare disease identifies new candidate diagnoses in the National Genomic Research Library.

medRxiv : the preprint server for health sciences·2026
Same author

Development of a Complementation Assay to Monitor Pan-Coronavirus 3C-like Protease Activity.

Viruses·2026
Same author

Common and rare variant analyses reveal genetic factors underlying idiopathic pulmonary fibrosis and its shared aetiology with severe COVID-19.

EBioMedicine·2025
Same author

Global epidemiology of spondyloarthritis.

Nature reviews. Rheumatology·2025
Same author

Further Evidence That Chondrocalcinosis 1 (CCAL1) is a Confirmed Mendelian Phenotype With a Known Molecular Basis.

American journal of medical genetics. Part A·2025

Area of Science:

  • Genetics
  • Epidemiology
  • Immunology

Background:

  • Ankylosing spondylitis (AS) is a significant autoimmune disease.
  • The human leukocyte antigen B27 (HLA-B27) is a major genetic factor in AS.
  • Evidence suggests other genes contribute to AS susceptibility and disease characteristics.

Purpose of the Study:

  • To review the genetic epidemiology of AS.
  • To examine gene-mapping studies for AS.
  • To discuss future research directions in AS genetics.

Main Methods:

  • Review of genetic epidemiology studies in AS.
  • Analysis of gene-mapping studies.
  • Discussion of research findings.

Main Results:

Related Experiment Videos

  • HLA-B27 is a primary but not exclusive genetic determinant of AS.
  • Genetic factors influence AS disease susceptibility.
  • Other genes impact AS severity and associated features.

Conclusions:

  • Further research is needed to identify additional genes involved in AS.
  • Understanding the full genetic architecture of AS is crucial for targeted therapies.
  • Future studies should focus on comprehensive gene mapping and epidemiological analysis.